Form 8-K - Current report:
SEC Accession No. 0001171843-26-004094
Filing Date
2026-06-12
Accepted
2026-06-12 16:01:17
Documents
11
Period of Report
2026-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_061226.htm   iXBRL 8-K 29615
  Complete submission text file 0001171843-26-004094.txt   194891

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crvs-20260611.xsd EX-101.SCH 3026
3 XBRL LABEL FILE crvs-20260611_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE crvs-20260611_pre.xml EX-101.PRE 22366
14 EXTRACTED XBRL INSTANCE DOCUMENT f8k_061226_htm.xml XML 3235
Mailing Address 901 GATEWAY BLVD, THIRD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD, THIRD FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 261086417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)